Impax Laboratories (IPXL) Misses Q1 EPS by 9c

May 11, 2015 4:03 PM EDT

Impax Laboratories (NASDAQ: IPXL) reported Q1 EPS of $0.09, $0.09 worse than the analyst estimate of $0.18. Revenue for the quarter came in at $143.1 million versus the consensus estimate of $146 million.

For earnings history and earnings-related data on Impax Laboratories (IPXL) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings